Clinical Trial Update: Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab in combination with chemotherapy as first-line therapy for metastatic colorectal cancer with liver or lung metastases has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: National Cancer Institute, France | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED